Merck Takes On Amgen, Regeneron, Lowering Stubbornly High Cholesterol By 60%

Published 6 hours ago Positive
Merck Takes On Amgen, Regeneron, Lowering Stubbornly High Cholesterol By 60%

Related Stocks

AMGN.US Amgen Inc
Merck said Saturday its new pill — a potential rival to Regeneron and Amgen — lowered stubbornly high cholesterol by almost 60%.

Continue Reading

View Comments

More News

Investing in United Overseas Bank (SGX:U11) five years ago would have delivered you a 104% gain

1 hour ago Positive

Analyst Estimates: Here's What Brokers Think Of Macquarie Group Limited (ASX:MQG) After Its Interim Report

1 hour ago Positive

Online Casino Bonus Leader Lucky Creek Casino Recognized by CasinoTop10.net for 2025 Promotions Excellence

1 hour ago Positive

NFL Betting Sites: Bovada NFL Betting Recognized in CasinoTop10’s 2025 Sportsbook Rankings

1 hour ago Positive

Looking at the Narrative for Medpace as Analyst Sentiment and Growth Outlook Shift

1 hour ago Positive